HK Stock Market Move | Risk aversion sentiment rising supports gold price. CHINAGOLDINTL (02099) up more than 6%, LINGBAO GOLD (03330) up more than 4%.
Most gold stocks are rising, as of the time of writing, China Gold International (02099) is up 6.1%, at 177.3 Hong Kong dollars; Lingbao Gold (03330) is up 4.4%, at 21.36 Hong Kong dollars.
Most gold stocks are rising, as of the deadline, CHINAGOLDINTL (02099) is up 6.1% at HKD 177.3; LINGBAO GOLD (03330) is up 4.4% at HKD 21.36; ZIJIN GOLD INTL (02259) is up 3.59% at HKD 158.5; and Chifeng Jilong Gold Mining (06693) is up 2.52% at HKD 30.96.
On the news front, risk aversion sentiment is significantly increasing.
On Monday, gold first broke through the $4600 mark, hitting a new all-time high. Concerns have been raised about the independence of the Federal Reserve as Powell is suddenly under investigation. In addition, the market continues to monitor developments in the situation with Iran. According to CCTV news, on the 12th local time, the U.S. State Department has instructed American citizens to leave Iran immediately. In recent days, protests have erupted in various parts of Iran, resulting in riots and casualties among security personnel and civilians. Citi predicts that gold prices will reach $5000 per ounce and silver prices will reach $100 within three months.
Related Articles
.png)
HK Stock Market Move | SINO BIOPHARM(01177) rises more than 4%, management is optimistic about the prospects of VIIa being included in insurance coverage. The drug is developed by its subsidiary, Zhongda Tianqing.

HK Stock Market Move | IMMUNEONCO-B(01541) rose by more than 10% in early trading. IMM01 has been approved for clinical trials for the treatment of atherosclerosis.

Furui: Lower target price of LAOPU GOLD (06181) to 981 Hong Kong dollars. High gold prices suppress gross profit.
HK Stock Market Move | SINO BIOPHARM(01177) rises more than 4%, management is optimistic about the prospects of VIIa being included in insurance coverage. The drug is developed by its subsidiary, Zhongda Tianqing.
.png)
HK Stock Market Move | IMMUNEONCO-B(01541) rose by more than 10% in early trading. IMM01 has been approved for clinical trials for the treatment of atherosclerosis.

Furui: Lower target price of LAOPU GOLD (06181) to 981 Hong Kong dollars. High gold prices suppress gross profit.

RECOMMEND

Patent Cliff Looms As Pharmaceutical Sector Prepares For A New Round Of Asset Competition
10/01/2026

Goldman Sachs Remains Bullish On China Equities: AI And Overseas Expansion To Drive Earnings, MSCI China Seen Rising 20% In 2026
10/01/2026

“A+H” Popularity Continues As Multiple A‑Share Companies Announce Hong Kong Listings At The Start Of The Year
10/01/2026


